Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000990973 | SCV001142047 | pathogenic | Adrenoleukodystrophy | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003489996 | SCV004238406 | likely pathogenic | not provided | 2023-02-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000990973 | SCV004298758 | likely pathogenic | Adrenoleukodystrophy | 2023-06-02 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCD1 protein function. ClinVar contains an entry for this variant (Variation ID: 804104). This missense change has been observed in individual(s) with adrenoleukodystrophy (PMID: 12175782). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 114 of the ABCD1 protein (p.Leu114Pro). |